Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$5.80+0.59 (+11.32%)
Close on Nov 17, 2026Market cap $86.90MP/E –Yield –
Cumberland Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cumberland Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$9.63M. For fiscal 2025 it was -$2.79M. The highest annual figure on record is $9.85M in fiscal 2011.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.79M | – |
| FY2024 | Dec 31, 2024 | -$6.43M | – |
| FY2023 | Dec 31, 2023 | -$9.55M | – |
| FY2022 | Dec 31, 2022 | -$5.70M | – |
| FY2021 | Dec 31, 2021 | -$7.68M | – |
| FY2020 | Dec 31, 2020 | -$6.38M | – |
| FY2019 | Dec 31, 2019 | -$9.29M | – |
| FY2018 | Dec 31, 2018 | -$11.17M | – |
| FY2017 | Dec 31, 2017 | -$4.08M | – |
| FY2016 | Dec 31, 2016 | -$1.43M | -228.9% |
| FY2015 | Dec 31, 2015 | $1.11M | -68.8% |
| FY2014 | Dec 31, 2014 | $3.56M | – |
| FY2013 | Dec 31, 2013 | -$3.80M | -143.1% |
| FY2012 | Dec 31, 2012 | $8.82M | -10.5% |
| FY2011 | Dec 31, 2011 | $9.85M | +51.5% |
| FY2010 | Dec 31, 2010 | $6.50M | +12.6% |
| FY2009 | Dec 31, 2009 | $5.78M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.13M | -342.2% |
| Q4 FY2025 | Dec 31, 2025 | -$1.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.12M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.29M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.84M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.03M | -4591.4% |
| Q1 FY2024 | Mar 31, 2024 | -$1.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.87M | – |
| Q2 FY2023 | Jun 30, 2023 | $22.86K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.28M | – |
| Q3 FY2022 | Sep 30, 2022 | -$288.59K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.35M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.56M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.44M | – |
| Q1 FY2021 | Mar 31, 2021 | -$324.30K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.75M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.85M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.39M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.20M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.37M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.26M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.81M | – |
| Q2 FY2018 | Jun 30, 2018 | -$868.98K | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$903.33K | – |
| Q3 FY2017 | Sep 30, 2017 | -$839.35K | -745.0% |
| Q2 FY2017 | Jun 30, 2017 | -$1.68M | – |
| Q1 FY2017 | Mar 31, 2017 | -$657.80K | – |
| Q4 FY2016 | Dec 31, 2016 | -$957.37K | – |
| Q3 FY2016 | Sep 30, 2016 | $130.13K | – |
See a number that looks wrong?